{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:22:40Z","timestamp":1787430160631,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016958","name":"National Institutes of Health Office of Research Infrastructure Programs","doi-asserted-by":"publisher","award":["5R01AI131648"],"award-info":[{"award-number":["5R01AI131648"]}],"id":[{"id":"10.13039\/100016958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-11-IDEX-0004-02"],"award-info":[{"award-number":["ANR-11-IDEX-0004-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-16-RHUS-0001"],"award-info":[{"award-number":["ANR-16-RHUS-0001"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01AI131648"],"award-info":[{"award-number":["5R01AI131648"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ard.2026.07.021","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:36:12Z","timestamp":1787139372000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3307-0446","authenticated-orcid":false,"given":"Nicolas","family":"Tchitchek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Rosenzwajg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Lorenzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darawan","family":"Rinchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Chaussabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Klatzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ard.2026.07.021_bib0001","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ard.2026.07.021_bib0002","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ard.2026.07.021_bib0003","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/ard-2022-222501","article-title":"Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial","volume":"81","author":"Humrich","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2026.07.021_bib0004","doi-asserted-by":"crossref","first-page":"fcab141","DOI":"10.1093\/braincomms\/fcab141","article-title":"Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2","volume":"3","author":"Giovannelli","year":"2021","journal-title":"Brain Commun"},{"key":"10.1016\/j.ard.2026.07.021_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111273","article-title":"IL-2\/anti-IL-2 complexes attenuates neuroinflammation and neurodegeneration in mice of experimental Parkinson\u2019s disease","volume":"223","author":"Li","year":"2025","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.ard.2026.07.021_bib0006","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1007\/s00415-023-11690-6","article-title":"A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing-remitting multiple sclerosis","volume":"270","author":"Louapre","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.ard.2026.07.021_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062602","article-title":"Low-dose interleukin 2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial","volume":"12","author":"Sriranjan","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ard.2026.07.021_bib0008","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1182\/blood-2011-11-392324","article-title":"Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells","volume":"119","author":"Duhen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ard.2026.07.021_bib0009","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89278","article-title":"Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells","volume":"1","author":"Hirakawa","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.ard.2026.07.021_bib0010","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/mt.2014.50","article-title":"Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers","volume":"22","author":"Ito","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.ard.2026.07.021_bib0011","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.0105-2896.2006.00423.x","article-title":"Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation","volume":"212","author":"Izcue","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ard.2026.07.021_bib0012","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1158\/2159-8290.CD-19-0958","article-title":"Regulatory T-cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis","volume":"10","author":"Zhang","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ard.2026.07.021_bib0013","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2026.07.021_bib0014","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.ard.2026.07.021_bib0015","doi-asserted-by":"crossref","first-page":"D988","DOI":"10.1093\/nar\/gkab1049","article-title":"Ensembl 2022","volume":"50","author":"Cunningham","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ard.2026.07.021_bib0016","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ard.2026.07.021_bib0017","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/0962280211428386","article-title":"Finding consistent patterns: a nonparametric approach for identifying differential expression in RNA-Seq data","volume":"22","author":"Li","year":"2013","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.ard.2026.07.021_bib0018","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3389\/fphar.2019.00445","article-title":"The NCATS BioPlanet \u2013 an integrated platform for exploring the universe of cellular signaling pathways for toxicology, systems biology, and chemical genomics","volume":"10","author":"Huang","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ard.2026.07.021_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.90","article-title":"Gene set knowledge discovery with Enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Curr Protoc"},{"key":"10.1016\/j.ard.2026.07.021_bib0020","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/bioinformatics\/btab121","article-title":"BloodGen3Module: blood transcriptional module repertoire analysis and visualization using R","volume":"37","author":"Rinchai","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ard.2026.07.021_bib0021","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ard.2026.07.021_bib0022","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2105-14-219","article-title":"TCC: an R package for comparing tag count data with robust normalization strategies","volume":"14","author":"Sun","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ard.2026.07.021_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.ard.2026.07.021_bib0024","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ard.2026.07.021_bib0025","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.183676","article-title":"BLIMP-1 and CEACAM1 cooperatively regulate human Treg homeostasis and function to control xenogeneic GVHD","volume":"10","author":"Ding","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.ard.2026.07.021_bib0026","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood-2012-09-435057","article-title":"The CD300 molecules: an emerging family of regulators of the immune system","volume":"121","author":"Borrego","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ard.2026.07.021_bib0027","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1073\/pnas.1500937112","article-title":"Cysteine cathepsins are essential in lysosomal degradation of \u03b1-synuclein","volume":"112","author":"McGlinchey","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ard.2026.07.021_bib0028","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/6809","article-title":"Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene","volume":"21","author":"Torrents","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.ard.2026.07.021_bib0029","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/hep.29812","article-title":"Carcinoembryonic antigen-related cell adhesion molecule 1 controls IL-2-dependent regulatory T-cell induction in immune-mediated hepatitis in mice","volume":"68","author":"Horst","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ard.2026.07.021_bib0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/sji.12330","article-title":"Systemic lupus erythematosus \u2013 a disease with a dysregulated type I interferon system","volume":"82","author":"Hagberg","year":"2015","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.ard.2026.07.021_bib0031","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/BOR.0b013e32835c7e32","article-title":"The interferon signature in autoimmune diseases","volume":"25","author":"R\u00f6nnblom","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ard.2026.07.021_bib0032","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13567-016-0392-3","article-title":"Distinct functional enrichment of transcriptional signatures in pigs with high and low IFN-gamma responses after vaccination with a porcine reproductive and respiratory syndrome virus (PRRSV)","volume":"47","author":"Ait-Ali","year":"2016","journal-title":"Vet Res"},{"key":"10.1016\/j.ard.2026.07.021_bib0033","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.4049\/jimmunol.1300293","article-title":"Tick-borne encephalitis (TBE) and hepatitis B nonresponders feature different immunologic mechanisms in response to TBE and influenza vaccination with involvement of regulatory T and B cells and IL-10","volume":"191","author":"Garner-Spitzer","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.ard.2026.07.021_bib0034","doi-asserted-by":"crossref","first-page":"eabm5505","DOI":"10.1126\/sciimmunol.abm5505","article-title":"Innate immunological pathways in COVID-19 pathogenesis","volume":"7","author":"Paludan","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ard.2026.07.021_bib0035","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.1038\/s41467-022-34895-1","article-title":"Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity","volume":"13","author":"Smith","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ard.2026.07.021_bib0036","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4049\/jimmunol.1300377","article-title":"Guanylate binding protein 1-mediated interaction of T cell antigen receptor signaling with the cytoskeleton","volume":"192","author":"Forster","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.ard.2026.07.021_bib0037","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/MCB.00664-13","article-title":"Gamma interferon-induced guanylate binding protein 1 is a novel actin cytoskeleton remodeling factor","volume":"34","author":"Ostler","year":"2014","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ard.2026.07.021_bib0038","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.immuni.2011.03.010","article-title":"Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells","volume":"34","author":"Saitoh","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.ard.2026.07.021_bib0039","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.meegid.2014.10.006","article-title":"Polymorphisms in the CISH gene are associated with susceptibility to tuberculosis in the Chinese Han population","volume":"28","author":"Ji","year":"2014","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ard.2026.07.021_bib0040","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa0905606","article-title":"CISH and susceptibility to infectious diseases","volume":"362","author":"Khor","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ard.2026.07.021_bib0041","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/mr\/roac140","article-title":"Interferons and systemic lupus erythematosus: pathogenesis, clinical features, and treatments in interferon-driven disease","volume":"33","author":"Tanaka","year":"2023","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.ard.2026.07.021_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1046687","article-title":"Targeting type I interferons in systemic lupus erythematous","volume":"13","author":"Bruera","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ard.2026.07.021_bib0043","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1191\/0961203304lu1025oa","article-title":"Targeting interferon-\u03b1: a promising approach for systemic lupus erythematosus therapy","volume":"13","author":"Schmidt","year":"2004","journal-title":"Lupus"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726004784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726004784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:26:24Z","timestamp":1787426784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496726004784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"alternative-id":["S0003496726004784"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.07.021","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}